Cleerly LABS vs TeraRecon Cardiovascular.Calcification.CT
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is a comprehensive, AI-powered analysis of coronary CT angiography to detect, quantify, and characterize all types of atherosclerosis and stenosis. This tool is ideal for clinicians seeking detailed plaque assessment, including volume and type, and the ability to track disease progression over time for highly personalized heart disease management and risk stratification.
View Cleerly LABS →Choose TeraRecon Cardiovascular.Calcification.CT if…
Choose TeraRecon Cardiovascular.Calcification.CT if your main requirement is automated and efficient detection and measurement of coronary artery calcifications for calcium scoring systems. This solution is best suited for facilities looking to streamline their cardiac CT workflow with a subscription-based model, providing accurate Agatston, volume, and mean mass scores, potentially as part of a broader suite for vessel and cardiac structure analysis.
View TeraRecon Cardiovascular.Calcification.CT →When choosing between Cleerly LABS and TeraRecon Cardiovascular.Calcification.CT, physicians should consider their primary diagnostic focus and workflow integration. Cleerly LABS excels at a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. It provides detailed plaque assessment, including volume and type, and offers 3D visualization, making it ideal for personalized heart disease risk assessment and tracking disease progression over time. The key practical difference lies in Cleerly LABS’s broader scope, offering a more in-depth look at the entire atherosclerotic burden beyond just calcification.
In contrast, TeraRecon Cardiovascular.Calcification.CT is specifically designed for the automatic detection and measurement of calcifications in coronary arteries, providing a mask for calcium scoring systems. It supports various measurements like Agatston score, volume, and mean mass, and integrates with other cardiac analysis features within the Eureka Clinical AI platform, such as vessel segmentation and functional analysis. The practical distinction is that TeraRecon focuses on calcification scoring and broader cardiac structural analysis, while Cleerly LABS provides a more granular assessment of plaque characteristics and stenosis. Physicians primarily focused on detailed plaque characterization and progression tracking for comprehensive heart disease management may find Cleerly LABS more suitable. Those who prioritize automated calcium scoring, alongside other cardiac structural and functional analysis within a unified platform, might prefer TeraRecon Cardiovascular.Calcification.CT.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | TeraRecon Cardiovascular.Calcification.CT |
|---|---|---|
| Pricing | Per analysis | Subscription-based |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Containerized application (SaMD), also available as SaaS within Eureka Clinical AI platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS is described as a 'web-based software' with an 'interactive web platform' for physicians to review results in depth, suggesting a user-friendly interface for comprehensive analysis and visualization. TeraRecon is a 'containerized application' or 'SaaS within Eureka Clinical AI platform,' which, while offering automation, doesn't explicitly highlight the same level of interactive web-based clinician experience for detailed review.
Clinical Value
Cleerly LABSCleerly LABS offers a more comprehensive clinical assessment by detecting, quantifying, and characterizing atherosclerosis and stenosis, including plaque volume and type, and ischemia detection with its ISCHEMIA module. This enables personalized heart disease risk assessment and tracking disease progression over time. TeraRecon primarily focuses on automatic detection and measurement of calcifications for calcium scoring systems, although it also offers vessel and cardiac structure analysis as part of a broader package.
Pricing & Value
TeraRecon Cardiovascular.Calcification.CTTeraRecon offers a subscription-based model with a single annual fee, providing predictable operational budgeting for institutions. Cleerly LABS has a 'per analysis' retail price of $1500, often resulting in out-of-pocket costs for patients, which can be a barrier to access despite some insurance coverage.
Enterprise Readiness
Cleerly LABSBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating foundational enterprise readiness. However, Cleerly LABS explicitly highlights 'Integration with PACS, RIS, EHR via Cleerly Proxy,' which is a critical aspect of seamless integration into existing healthcare IT workflows.
Innovation
Cleerly LABSCleerly LABS's focus on comprehensive plaque characterization (volume, type), stenosis, and ischemia detection, coupled with its mission to 'eliminate heart attacks by creating a new standard of care,' demonstrates a higher degree of innovation in advancing personalized cardiovascular risk assessment and management. TeraRecon's automation of calcification scoring and other cardiac analyses is valuable, but Cleerly's broader, more detailed diagnostic capabilities for disease progression tracking appear to be more groundbreaking.
Support & Docs
TieBoth companies are established in the healthcare AI space and offer standard customer support channels. TeraRecon explicitly mentions a dedicated support portal, technical support, and user manuals, including for Cardiovascular.Calcification.CT. Cleerly also provides support contact options and resources for clinicians. Without more specific comparative details on the depth or breadth of their support and documentation, it is difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | TeraRecon Cardiovascular.Calcification.CT |
|---|---|---|
| Name | Cleerly LABS | TeraRecon Cardiovascular.Calcification.CT |
| Company | Cleerly | Terarecon |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered software as a medical device (SaMD) that analyzes CT images to automatically detect and measure calcifications in the coronary arteries, providing a mask for calcium scoring systems. |
| Key Feature: Plaque Assessment | Comprehensive coronary plaque assessment (volume, type) | Automatic 3D segmentation of calcified plaques in coronary arteries |
| Key Feature: Stenosis Detection | Stenosis detection and quantification | Vessel segmentation and analysis (plaque, stenosis, curvature, tortuosity) |
| Key Feature: Calcium Scoring Output | Not specified | Outputs mask for calcium scoring systems; Supports Agatston score, volume, mean mass (mg) measurements |
| Key Feature: Ischemia Detection | Ischemia detection (with Cleerly ISCHEMIA module) | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and TeraRecon Cardiovascular.Calcification.CT.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or TeraRecon Cardiovascular.Calcification.CT
Backers
Who funded each tool's parent company.